Bank Of America Corp Biotechnology

Bank Of America Corp

$1.19 Trillion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
EQ Equillium, Inc.	$25.8M	$0 0.0% of portfolio	467	Q3 2024 Added 195.57%
EPIX Essa Pharma Inc.	$79.3M	$0 0.0% of portfolio	8	Q2 2023 Reduced 99.63%
EYEN Eyenovia, Inc.	$3.08M	$0 0.0% of portfolio	421	Q3 2024 Reduced 99.32%
GLYC Glycomimetics Inc	$16.3M	$0 0.0% of portfolio	464	Q3 2024 Reduced 91.41%
HCWB Hcw Biologics Inc.	$21.5M	$0 0.0% of portfolio	339	Q3 2024 Added 117.31%
IMAB I Mab	$78.1M	$0 0.0% of portfolio	568	Q2 2024 Reduced 96.99%
IKNA Ikena Oncology, Inc.	$62M	$0 0.0% of portfolio	199	Q3 2024 Reduced 39.14%
IMMX Immix Biopharma, Inc.	$23.9M	$0 0.0% of portfolio	115	Q2 2024 New
INAB In8 Bio, Inc.	$7.35M	$0 0.0% of portfolio	420	Q3 2024 Added 57.89%
INDP Indaptus Therapeutics, Inc.	$8.51M	$0 0.0% of portfolio	60	Q3 2024 Added 42.86%
INM In Med Pharmaceuticals Inc.	$3.97M	$0 0.0% of portfolio	100	Q4 2023 Reduced 94.55%
LTRN Lantern Pharma Inc.	$34.3M	$0 0.0% of portfolio	65	Q3 2024 Reduced 5.8%
LEXX Lexaria Bioscience Corp.	$13.6M	$0 0.0% of portfolio	115	Q3 2024 Added 19.79%
MAIA Maia Biotechnology, Inc.	$23.8M	$0 0.0% of portfolio	156	Q3 2024 Added 13.87%
NERV Minerva Neurosciences, Inc.	$12.1M	$0 0.0% of portfolio	57	Q3 2024 Reduced 66.27%
NRXPW Nrx Pharmaceuticals Inc Wt Exp	$0	$0 0.0% of portfolio	95	Q2 2024 New
NTRB Nutri Band Inc.	$37.8M	$0 0.0% of portfolio	152	Q3 2024 Added 137.5%
OCUP Ocuphire Pharma, Inc.	$20.2M	$0 0.0% of portfolio	202	Q3 2024 Reduced 5.16%
ONVO Organovo Holdings, Inc.	$3.92M	$0 0.0% of portfolio	739	Q3 2024 Added 99.19%
PASG Passage Bio, Inc.	$33.8M	$0 0.0% of portfolio	425	Q3 2024 Added 15.8%
PMCB Pharma Cyte Biotech, Inc.	$35.1M	$0 0.0% of portfolio	117	Q3 2024 Reduced 23.03%
PHVS Pharvaris N.V.	$800M	$0 0.0% of portfolio	15	Q3 2024 Reduced 99.75%
TARA Protara Therapeutics, Inc.	$29.5M	$0 0.0% of portfolio	366	Q3 2024 Added 145.64%
RNXT Renovo Rx, Inc.	$11.7M	$0 0.0% of portfolio	196	Q3 2024 Added 7.69%
RVPH Reviva Pharmaceuticals Holdings, Inc.	$22.7M	$0 0.0% of portfolio	215	Q3 2024 Reduced 94.55%
SLS Sellas Life Sciences Group, Inc.	$24.5M	$0 0.0% of portfolio	526	Q3 2024 Reduced 8.84%
SNSE Sensei Biotherapeutics, Inc.	$18.4M	$0 0.0% of portfolio	258	Q3 2024 Added 85.61%
SILO Silo Pharma, Inc.	$2.76M	$0 0.0% of portfolio	36	Q3 2024 Added 111.76%
SPRB Spruce Biosciences, Inc.	$12.3M	$0 0.0% of portfolio	223	Q3 2024 Added 48.67%
SRZNW Surrozen Inc Wt Exp 08/01/31 (	$0	$0 0.0% of portfolio	100	Q2 2024 New
UNCY Unicycive Therapeutics, Inc.	$8.43M	$0 0.0% of portfolio	332	Q3 2024 Added 48.88%
VINC Vincerx Pharma, Inc.	$5.72M	$0 0.0% of portfolio	211	Q3 2024 Added 0.48%
VIRI Virios Therapeutics, Inc.	$81.4M	$0 0.0% of portfolio	211	Q3 2024 Added 51.8%
XLO Xilio Therapeutics, Inc.	$24.2M	$0 0.0% of portfolio	266	Q3 2024 Reduced 61.56%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.